Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Hommes

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Gastroenterology|July 1, 1995
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)H M van Dullemen, S J van Deventer, D W Hommes, et al.
Haemostasis|December 9, 1998
Beneficial effect of treatment with a monoclonal anti-tumor necrosis factor-alpha antibody on markers of coagulation and fibrinolysis in patients with active Crohn's diseaseD W Hommes, H M van Dullemen, M Levi, et al.
Lancet (London, England)|February 2, 1991
Mortality in hereditary antithrombin-III deficiency--1830 to 1989F R Rosendaal, H Heijboer, E Briët, et al.
Inflammatory Bowel Diseases|January 4, 2013
Production and cellular source of interleukin-8 in ulcerative colitisD W Hommes, S A Radema, J Jansen, et al.
Gut|April 1, 1996
Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammationD W Hommes, J Meenan, M de Haas, et al.
Journal of Crohn'S & Colitis|June 19, 2012
Subgroup analysis of the placebo-controlled CHARM trial: increased remission rates through 3 years for adalimumab-treated patients with early Crohn's diseaseS Schreiber, W Reinisch, J F Colombel, et al.
European Journal of Gastroenterology & Hepatology|June 1, 1996
Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitisJ Meenan, T A Grool, D W Hommes, et al.
Endoscopy|March 27, 2007
Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitisE Dekker, F J van den Broek, J B Reitsma, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2006
Pancytopenia due to high 6-methylmercaptopurine levels in a 6-mercaptopurine treated patient with Crohn's diseaseL P L Gilissen, L J J Derijks, H M J H Verhoeven, et al.
Gut|March 2, 2006
Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's diseaseD W Hommes, T L Mikhajlova, S Stoinov, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Gastroenterology|July 1, 1995
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)H M van Dullemen, S J van Deventer, D W Hommes, et al.
Haemostasis|December 9, 1998
Beneficial effect of treatment with a monoclonal anti-tumor necrosis factor-alpha antibody on markers of coagulation and fibrinolysis in patients with active Crohn's diseaseD W Hommes, H M van Dullemen, M Levi, et al.
Lancet (London, England)|February 2, 1991
Mortality in hereditary antithrombin-III deficiency--1830 to 1989F R Rosendaal, H Heijboer, E Briët, et al.
Inflammatory Bowel Diseases|January 4, 2013
Production and cellular source of interleukin-8 in ulcerative colitisD W Hommes, S A Radema, J Jansen, et al.
Gut|April 1, 1996
Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammationD W Hommes, J Meenan, M de Haas, et al.
Journal of Crohn'S & Colitis|June 19, 2012
Subgroup analysis of the placebo-controlled CHARM trial: increased remission rates through 3 years for adalimumab-treated patients with early Crohn's diseaseS Schreiber, W Reinisch, J F Colombel, et al.
European Journal of Gastroenterology & Hepatology|June 1, 1996
Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitisJ Meenan, T A Grool, D W Hommes, et al.
Endoscopy|March 27, 2007
Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitisE Dekker, F J van den Broek, J B Reitsma, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2006
Pancytopenia due to high 6-methylmercaptopurine levels in a 6-mercaptopurine treated patient with Crohn's diseaseL P L Gilissen, L J J Derijks, H M J H Verhoeven, et al.
Gut|March 2, 2006
Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's diseaseD W Hommes, T L Mikhajlova, S Stoinov, et al.
Pageof 6